Concepts (90)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetic Angiopathies | 2 | 2024 | 811 | 0.770 |
Why?
|
| Scleroderma, Limited | 1 | 2017 | 8 | 0.590 |
Why?
|
| Sunlight | 1 | 2018 | 333 | 0.560 |
Why?
|
| Facial Dermatoses | 1 | 2017 | 84 | 0.550 |
Why?
|
| Thyroxine | 2 | 2017 | 665 | 0.540 |
Why?
|
| Hashimoto Disease | 1 | 2017 | 95 | 0.530 |
Why?
|
| Atrioventricular Block | 1 | 2017 | 121 | 0.510 |
Why?
|
| Graves Disease | 1 | 2017 | 240 | 0.500 |
Why?
|
| Hypothyroidism | 2 | 2017 | 662 | 0.500 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2016 | 261 | 0.420 |
Why?
|
| Hepatitis B, Chronic | 1 | 2016 | 400 | 0.400 |
Why?
|
| Insulin-Secreting Cells | 1 | 2019 | 893 | 0.400 |
Why?
|
| Diabetes Mellitus, Type 1 | 3 | 2021 | 3333 | 0.380 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2024 | 11966 | 0.360 |
Why?
|
| Urban Population | 1 | 2018 | 1990 | 0.360 |
Why?
|
| Philippines | 3 | 2022 | 97 | 0.350 |
Why?
|
| Diabetes Mellitus | 1 | 2024 | 5776 | 0.250 |
Why?
|
| Environmental Exposure | 1 | 2018 | 4320 | 0.230 |
Why?
|
| Hormone Replacement Therapy | 2 | 2017 | 742 | 0.190 |
Why?
|
| Retinal Neurons | 1 | 2021 | 66 | 0.190 |
Why?
|
| Pyruvate Kinase | 1 | 2022 | 190 | 0.180 |
Why?
|
| Bipolar Disorder | 1 | 2017 | 5050 | 0.170 |
Why?
|
| Glucose Clamp Technique | 1 | 2019 | 247 | 0.160 |
Why?
|
| HLA-A Antigens | 1 | 2019 | 230 | 0.160 |
Why?
|
| Podocytes | 1 | 2022 | 416 | 0.150 |
Why?
|
| C-Peptide | 1 | 2019 | 424 | 0.150 |
Why?
|
| Methimazole | 1 | 2017 | 41 | 0.150 |
Why?
|
| Antithyroid Agents | 1 | 2017 | 70 | 0.140 |
Why?
|
| Adipose Tissue, Brown | 1 | 2022 | 756 | 0.140 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2022 | 1094 | 0.130 |
Why?
|
| Diabetic Retinopathy | 2 | 2021 | 1246 | 0.130 |
Why?
|
| Retinal Vessels | 1 | 2021 | 823 | 0.130 |
Why?
|
| Diabetic Nephropathies | 1 | 2022 | 1016 | 0.120 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2021 | 1484 | 0.120 |
Why?
|
| Dyslipidemias | 1 | 2022 | 876 | 0.120 |
Why?
|
| Iodine Radioisotopes | 1 | 2017 | 1029 | 0.110 |
Why?
|
| Neck | 1 | 2017 | 703 | 0.100 |
Why?
|
| Fatal Outcome | 1 | 2016 | 1823 | 0.100 |
Why?
|
| Steroids | 1 | 2016 | 919 | 0.090 |
Why?
|
| Autoantibodies | 1 | 2019 | 2042 | 0.090 |
Why?
|
| C-Reactive Protein | 1 | 2022 | 3752 | 0.090 |
Why?
|
| Methotrexate | 1 | 2017 | 1719 | 0.090 |
Why?
|
| Insulin | 2 | 2022 | 6481 | 0.090 |
Why?
|
| Endothelium, Vascular | 1 | 2021 | 4414 | 0.080 |
Why?
|
| Insulin Resistance | 1 | 2021 | 3841 | 0.070 |
Why?
|
| Cognition | 2 | 2021 | 6786 | 0.070 |
Why?
|
| Atherosclerosis | 1 | 2022 | 3423 | 0.070 |
Why?
|
| Humans | 12 | 2024 | 746897 | 0.070 |
Why?
|
| Immunosuppressive Agents | 1 | 2017 | 4057 | 0.060 |
Why?
|
| Antiviral Agents | 1 | 2016 | 3014 | 0.060 |
Why?
|
| Inflammation | 1 | 2022 | 10642 | 0.050 |
Why?
|
| Male | 6 | 2022 | 351556 | 0.050 |
Why?
|
| Adult | 4 | 2022 | 215291 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 19827 | 0.040 |
Why?
|
| Retina | 2 | 2021 | 2623 | 0.040 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2021 | 552 | 0.040 |
Why?
|
| Endothelial Cells | 2 | 2022 | 3486 | 0.040 |
Why?
|
| Aged | 3 | 2021 | 164472 | 0.040 |
Why?
|
| Female | 5 | 2022 | 382617 | 0.040 |
Why?
|
| Capillaries | 1 | 2021 | 767 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 38812 | 0.040 |
Why?
|
| Time Factors | 1 | 2019 | 39639 | 0.040 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2021 | 678 | 0.040 |
Why?
|
| Risk Factors | 1 | 2024 | 72453 | 0.040 |
Why?
|
| Middle Aged | 3 | 2021 | 214711 | 0.030 |
Why?
|
| Apolipoproteins E | 1 | 2022 | 1421 | 0.030 |
Why?
|
| Angiography | 1 | 2021 | 1597 | 0.030 |
Why?
|
| HIV Infections | 1 | 2022 | 16939 | 0.030 |
Why?
|
| Metabolome | 1 | 2022 | 949 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2021 | 1482 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2022 | 2129 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 13581 | 0.030 |
Why?
|
| Regeneration | 1 | 2022 | 1490 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2021 | 2434 | 0.030 |
Why?
|
| Anti-Retroviral Agents | 1 | 2022 | 1755 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2021 | 2868 | 0.020 |
Why?
|
| Child | 1 | 2019 | 78517 | 0.020 |
Why?
|
| Adolescent | 1 | 2019 | 86323 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2022 | 3475 | 0.020 |
Why?
|
| Young Adult | 1 | 2016 | 57221 | 0.020 |
Why?
|
| Tomography, Optical Coherence | 1 | 2021 | 2812 | 0.020 |
Why?
|
| Animals | 3 | 2022 | 166593 | 0.020 |
Why?
|
| Mice | 2 | 2022 | 80291 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2022 | 21608 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2021 | 21702 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 17878 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 25197 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2021 | 40540 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2021 | 23158 | 0.010 |
Why?
|
| United States | 1 | 2021 | 70460 | 0.010 |
Why?
|
Concepts
(90)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(9)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_